Gudrun Hilgard

Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial

Man‐Fung Yuen, Tarik Asselah, Ira M. Jacobson et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 64 citations

Ide Analogues, Viral Hepatitis, Medicine +10

GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients

Clemens Schotten, Bastian Ostertag, Jan‐Peter Sowa et al. · Pharmaceuticals · 2021 · 52 citations · Full text

Adaptation of the hepatitis B virus core protein to CD8+ T‐cell selection pressure

Helenie Kefalakes, Bettina Budeus, Andreas Walker et al. · Hepatology · 2015 · 51 citations

Experience and impact of stigma in people with chronic hepatitis B: a qualitative study in Asia, Europe, and the United States

Mondher Toumi, Jack Wallace, Chari Cohen et al. · BMC Public Health · 2024 · 25 citations · Full text

Bulevirtide monotherapy at low and high dose in patients with chronic hepatitis delta: 24 weeks interim data of the phase 3 MYR301 study

Heiner Wedemeyer, Soo Aleman, Pietro Andreoné et al. · Digestive and Liver Disease · 2022 · 19 citations

Hepatology, High Dose, Viral Hepatitis +7